Search Results - "Dohke, Tomohiro"

Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention by Takeda, Teruki, Dohke, Tomohiro, Ueno, Yoshiki, Mastui, Toshiki, Fujii, Masanori, Takayama, Tomoyuki, Dochi, Kenichi, Miyamoto, Akashi, Mabuchi, Hiroshi, Wada, Atsuyuki

“…No predictive clinical risk scores for net adverse clinical events (NACE) have been developed for patients with atrial fibrillation (AF) after percutaneous…”
Get full text

Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2 by Chatani, Ryuki, Yamashita, Yugo, Morimoto, Takeshi, Mushiake, Kazunori, Kadota, Kazushige, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Kimura, Takeshi

“…There is a paucity of data on real-world management strategies and clinical outcomes of cancer-associated venous thromboembolism (VTE) in the direct oral…”
Get full text

Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism　― From the COMMAND VTE Registry-2 by Ikeda, Shinya, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Ono, Koh, Kimura, Takeshi

“…Background: White blood cell (WBC) counts were reported to be a risk factor for acute adverse events in patients with venous thromboembolism (VTE). However,…”
Get full text

Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　― A Predetermined Companion Report From the ONCO PE Trial by Chatani, Ryuki, Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Shioyama, Wataru, Shibata, Tatsuhiro, Nishimoto, Yuji, Ogihara, Yoshito, Doi, Kosuke, Oi, Maki, Shiga, Taro, Sueta, Daisuke, Kim, Kitae, Tanabe, Yasuhiro, Koitabashi, Norimichi, Takada, Takuma, Ikeda, Satoshi, Nakagawa, Hitoshi, Mitsuhashi, Takayuki, Shoji, Masaaki, Sakamoto, Jiro, Hisatake, Shinji, Ogino, Yutaka, Fujita, Masashi, Nakanishi, Naohiko, Dohke, Tomohiro, Hiramori, Seiichi, Nawada, Ryuzo, Kaneda, Kazuhisa, Mushiake, Kazunori, Yamamoto, Hiromi, Kadota, Kazushige, Ono, Koh, Kimura, Takeshi, on behalf of the ONCO PE Trial Investigators

“…Background: Patients with appropriately selected low-risk pulmonary embolism (PE) can be treated at home, although it has been controversial whether applies to…”
Get full text

Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2 by Ikeda, Nobutaka, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Kimura, Takeshi

“…Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening complication post-acute pulmonary embolism (PE). The assessment of CTEPH incidence…”
Get full text

Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants by Nishikawa, Ryusuke, Yamashita, Yugo, Morimoto, Takeshi, Kaneda, Kazuhisa, Chatani, Ryuki, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Ono, Koh, Kimura, Takeshi

“…The simplified Pulmonary Embolism Severity Index (sPESI) score could help identify low-risk patients with pulmonary embolism for home treatment. However, the…”
Get full text

Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era by Kaneda, Kazuhisa, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Ono, Koh, Kimura, Takeshi

“…There have been limited data on the changes in clinical outcomes after the introduction of direct oral anticoagulants (DOACs) for venous thromboembolism (VTE)…”
Get full text

Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2 by Takabayashi, Kensuke, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Ono, Koh, Kimura, Takeshi

“…Abstract Background Extracorporeal membrane oxygenation (ECMO) might be required as a treatment option in patients with critical pulmonary embolism (PE)…”
Get full text

Proteomic Analysis Reveals Significant Alternations of Cardiac Small Heat Shock Protein Expression in Congestive Heart Failure by Dohke, Tomohiro, Wada, Atsuyuki, Isono, Takahiro, Fujii, Masanori, Yamamoto, Takashi, Tsutamoto, Takayoshi, Horie, Minoru

“…Because congestive heart failure (CHF) is a complex syndrome with many different underlying mechanisms of worsening of heart function, it is important to…”
Get full text

Endogenous Bradykinin Suppresses Myocardial Fibrosis through the Cardiac-generated Endothelin System Under Chronic Angiotensin-converting Enzyme Inhibition in Heart Failure by Fujii, Masanori, Wada, Atsuyuki, Ohnishi, Masato, Tsutamoto, Takayoshi, Matsumoto, Takehiro, Yamamoto, Takashi, Takayama, Tomoyuki, Dohke, Tomohiro, Isono, Takahiro, Eguchi, Yutaka, Horie, Minoru

“…In congestive heart failure, angiotensin-converting enzyme inhibitors (ACEIs) may prevent cardiac fibrosis via interaction with both angiotensin II and…”
Get full text

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial) by Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Shioyama, Wataru, Chatani, Ryuki, Shibata, Tatsuhiro, Nishimoto, Yuji, Ogihara, Yoshito, Doi, Kosuke, Oi, Maki, Shiga, Taro, Sueta, Daisuke, Kim, Kitae, Tanabe, Yasuhiro, Koitabashi, Norimichi, Takada, Takuma, Ikeda, Satoshi, Nakagawa, Hitoshi, Tsukahara, Kengo, Shoji, Masaaki, Sakamoto, Jiro, Hisatake, Shinji, Ogino, Yutaka, Fujita, Masashi, Nakanishi, Naohiko, Dohke, Tomohiro, Hiramori, Seiichi, Nawada, Ryuzo, Kaneda, Kazuhisa, Ono, Koh, Kimura, Takeshi

“…Background: The optimal duration of anticoagulation therapy for patients with cancer and acute low-risk pulmonary embolism (PE) is clinically relevant, but…”
Get full text

Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE Registry-2 by Shigeno, Ryo, Kim, Kitae, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Furukawa, Yutaka, Kimura, Takeshi

“…[Display omitted] •Initial single DOAC therapy could be a treatment option for acute PE.•However, the efficacy and safety for intermediate-high risk acute PE…”
Get full text

External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2 by Nishimoto, Yuji, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Sato, Yukihito, Watanabe, Tetsuya, Yamada, Takahisa, Fukunami, Masatake, Kimura, Takeshi, Kaneda, Kazuhisa, Nishikawa, Ryusuke, Yamashita, Yugo, Chatani, Ryuki, Mushiake, Kazunori, Kadota, Kazushige, Nishimoto, Yuji, Sato, Yukihito, Ikeda, Nobutaka, Amemiya, Katsushi, Nakamura, Masato, Kobayashi, Yohei, Kimura, Ren, Inada, Tsukasa, Ikeda, Satoshi, Ueno, Yuki, Maemura, Koji, Kim, Kitae, Shigeno, Ryo, Furukawa, Yutaka, inoko, Moriaki, Ito, Shinya, Takase, Toru, Nakazawa, Gaku, Tsuji, Shuhei, Toyofuku, Mamoru, Oi, Maki, Kaitani, Kazuaki, Takada, Takuma, Jujo, Kentaro, Hagiwara, Nobuhisa, Otsui, Kazunori, Mori, Kenta, Sakamoto, Jiro, Tamura, Toshihiro

“…There is no established risk score for anticoagulant-related bleeding during the acute phase in patients with pulmonary embolism (PE). The PE-Syncope, Anemia,…”
Get full text

Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis by Ikeda, Shinya, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Ono, Koh, Kimura, Takeshi

“…Patients with unprovoked venous thromboembolisms (VTEs) can be sub-classified based on the different phenotypes using a latent class analysis (LCA), which…”
Get full text

Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2 by Ogihara, Yoshito, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Sato, Toru, Nishikawa, Ryusuke, Kimura, Takeshi, Dohi, Kaoru

“…There is limited data on the safety of direct oral anticoagulants (DOACs) in fragile patients with venous thromboembolism (VTE). We used the COMMAND VTE…”
Get full text

Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2 by Mabuchi, Hiroshi, Nishikawa, Ryusuke, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Ono, Koh, Nakagawa, Yoshihisa, Kimura, Takeshi

“…Statins were reported to have a potential effect of primary prevention of venous thromboembolism (VTE), although that of secondary prevention remains…”
Get full text

Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart Failure by Tsutamoto, Takayoshi, Wada, Atsuyuki, Sakai, Hiroshi, Ishikawa, Chitose, Tanaka, Toshinari, Hayashi, Masaru, Fujii, Masanori, Yamamoto, Takashi, Dohke, Tomohiro, Ohnishi, Masato, Takashima, Hiroyuki, Kinoshita, Masahiko, Horie, Minoru

“…Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart Failure Takayoshi Tsutamoto, Atsuyuki Wada, Hiroshi Sakai,…”
Get full text

Incidence and Risk factors of Ischemic Stroke in Patients with Cancer-associated Venous Thromboembolism: From the COMMAND VTE Registry-2 by Sato, Toru, Ogihara, Yoshito, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Nishimoto, Yuji, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Kimura, Takeshi, Dohi, Kaoru

Get full text

External validation of the PE-SARD bleeding score for early major bleeding in patients with acute pulmonary embolism: From the COMMAND VTE Registry-2 by Nishimoto, Yuji, Yamashita, Yugo, Morimoto, Takeshi, Chatani, Ryuki, Kaneda, Kazuhisa, Ikeda, Nobutaka, Kobayashi, Yohei, Ikeda, Satoshi, Kim, Kitae, Inoko, Moriaki, Takase, Toru, Tsuji, Shuhei, Oi, Maki, Takada, Takuma, Otsui, Kazunori, Sakamoto, Jiro, Ogihara, Yoshito, Inoue, Takeshi, Usami, Shunsuke, Chen, Po-Min, Togi, Kiyonori, Koitabashi, Norimichi, Hiramori, Seiichi, Doi, Kosuke, Mabuchi, Hiroshi, Tsuyuki, Yoshiaki, Murata, Koichiro, Takabayashi, Kensuke, Nakai, Hisato, Sueta, Daisuke, Shioyama, Wataru, Dohke, Tomohiro, Nishikawa, Ryusuke, Sato, Yukihito, Watanabe, Tetsuya, Yamada, Takahisa, Fukunami, Masatake, Kimura, Takeshi

“…There is no established risk score for anticoagulant-related bleeding during the acute phase in patients with pulmonary embolism (PE). The Syncope, Anemia,…”
Get full text

Abstract 8978: NADPH Oxidase Inhibition Improves Cardiac Dysfunction Through Cardiac Mast Cell Stabilization and Suppression of the Renin-Angiotensin System by Matsumoto, Takehiro, Wada, Atsuyuki, Ohnishi, Masato, Fujii, Masanori, Yamamoto, Takashi, Dohke, Tomohiro, Takayama, Tomoyuki, Tsutamoto, Takayoshi, Horie, Minoru

“…Abstract only Reactive oxygen species (ROS) participate in the pathogenesis of cardiac inflammation and the activation of the renin-angiotensin (RA) system in…”
Get full text